Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis
Jennifer Kubon(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sven Wach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bastian Keck(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann(Universitätsklinikum Erlangen), Ralph M. Wirtz(Siemens Healthcare (Germany)), Veronika Weyerer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Markus Eckstein(Friedrich-Alexander-Universität Erlangen-Nürnberg), Danijel Sikic(Friedrich-Alexander-Universität Erlangen-Nürnberg), Angela Neumann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Helge Täubert(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 30
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386
Toward the blood-borne miRNome of human diseases
|Nature Methods|2011|364